Enhanced myocardial relaxation in vivo in transgenic mice overexpressing the β2-adrenergic receptor is associated with reduced phospholamban protein

Journal of Clinical Investigation

Volumn 97, Issue 7, 1996, Pages 1618-1623

  Rockman, Howard A ^a   Hamilton, Raeann ^a   Jones, Larry R ^c   Milano, Carmelo A ^b   Mao, Lan ^a   Lefkowitz, Robert J ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b DUKE UNIVERSITY   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

myocardial relaxation; phospholamban; sarcoplasmic reticulum; transgenic mice; adrenergic receptor

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; PHOSPHOLAMBAN;

ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; GENE EXPRESSION; HEART MUSCLE RELAXATION; HEMODYNAMICS; MICROSURGERY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DETERMINATION; TRANSGENIC MOUSE;

EID: 0029928188     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118587     Document Type: Article

References (31)

1. Tsien, R.W , B.P. Bean, P. Hess, J.B. Lansman, B. Nilius, and M.C. Nowycky, 1986 Mechanisms of calcium channel modulation by β-adrenergic agents and dihydropyridine calcium agonists. J. Mol Cell. Cardiol 18:691-710.
2. Solaro, R.J., A.J.G. Moir, and S.V. Perry. 1976. Phosphorylation of troponin I and inotropic effect of adrenaline in the perfused rabbit heart. Nature (Lond) 262:615-617.
3. 2+ uptake in mammalian ventricular myocytes. Am. J Physiol. 261:H1344-H1349.
4. 2+-ATPase activity in guinea pig ventricles. J Biol. Chem. 258:464-471.
5. Wegener, A D., J.P. Lindemann, H.K.B Simmerman, and J R. Jones. 1989 Phospholamban phosphorylation in intact ventricles. J Biol. Chem. 264: 11468-11474.
6. 2+ current in single rat ventricular cells. Circ. Res. 73.286-300.
7. 2+ dynamics, contractility, or phospholamban phosphorylation. J. Biol. Chem. 269:19151-19156.
8. 2-adrenergic receptor. Science (Wash. DC). 264:582-586.
9. Rockman, H.A., S.P. Wachhorst, L. Mao, and J. Ross, Jr. 1994. Angiotensin II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice. Am. J Physiol. 266:H2468-H2475.
10. Rockman, H.A., S. Ono, R.S. Ross, L.R. Jones, M. Karim, V. Bhargava, J. Ross, Jr., and K.R. Chien 1994. Molecular and physiological alterations in murine ventricular dysfunction. Proc. Nutl. Acad. Sci. USA. 91:2694-2698
11. Yellin, E L., M. Hori, C. Yoran, E.H. Sonnenblick, S. Gabbay, and R.W.M. Frater, 1986. Left ventricular relaxation in the filling and nonfilling intact canine heart. Am. J. Physiol. 250:H620-H629.
12. Weisfeldt, M.L., J.W. Frederiksen, F.C.P. Yin, and J L. Weiss. 1978. Evidence of incomplete left ventricular relaxation in the dog. J. Clin Invest 62: 1296-1302.
13. Blaustein, A.S , and W.H. Gaasch. 1983. Myocardial relaxation. VI. Effects of β-adrenergic tone and asynchrony on LV relaxation rate. Am. J. Physiol. 244.H417-H422
14. Lowry, O.H., N J. Rosebrough, A.L. Farr, and R.J. Randall. 1951 Protein measurement with the Folin phenol reagent. J. Biol Chem. 193:265-275.
15. Wegener, A.D., and J.R. Jones. 1984. Phosphorylation-induced mobility shift in phospholamban in sodium dodecyl sulfate-polyacrylamide gels. J. Biol. Chem 259.1834-1841.
16. 2+ transport ATPase of cardiac sarcoplasmic reticulum. J. Biol. Chem 268:1-3.
17. Ungerer, M., G. Parruti, M. Bohm, M. Puzicha, A. DeBlasi, E. Erdmann, and M.J. Lohse. 1993. Expression of β-arrestins and β-adrenergic receptor kinases in the failing human heart. Circ. Res. 74:206-213
18. Movsesian, M.A., M. Karimi, K. Green, and L.R. Jones. 1994. Ca(2+)-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation. 90:653-657.
19. Porzio, M A., and A.M. Pearson. 1977. Improved resolution of myofibrillar proteins with sodium dodecyl sulfate A-polyacrylamide gel electrophoresis. Biochim. Biophys. Acta 490.27-34.
20. Varma, S.K., R.M. Owen, M.L. Smucker, and M D. Feldman, 1989 Is τ a preload-independent measure of isovolumetric relaxation? Circulation. 80: 1757-1765.
21. 2+ mediated through α- and β-adrenoceptors. Circ Res. 62:247-265.
22. Luo, W., I.L. Grupp, J. Harrer, S. Ponniah, G. Grupp, J J. Duffy, T. Doetschman, and E.G. Kranias. 1994. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation. Circ. Res. 75:401-409.
23. Hoit, B.D , S.F. Koury, E.G. Kranias, N. Ball, and R Walsh. 1995. In vivo echocardiographic detection of enhanced left ventricular function in gene targeted mice with phospholamban deficiency. Circ. Res. 77:632-637.
24. Feldman, A.M., E.O. Weinberg, P.E. Ray, and B.H. Lorell. 1993. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ. Res. 73.184-192.
25. Arai, M., N.R. Alpert, D.H. MacLennan, P. Barton, and M. Periasamy. 1993. Alterations in sarcoplasmic reticulum gene expression in human heart failure: a possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ. Res. 72:463-469.
26. Feldman, A.M., P.E. Ray, C.M. Silan, J.A. Mercer, W Minobe, and M R. Bristow, 1991. Selective gene expression in failing human heart: quantification of steady-state levels of messenger RNA in endomyocardial biopsies using the polymerase chain reaction. Circulation. 83.1866-1872.
27. Bohm, M., B. Reiger, R.H.G. Schwinger, and E. Erdmann, 1994, cAMP concentrations, cAMP dependent protein kinase activity, and phospholamban in non-failing and failing myocardium Cardiovasc. Res 28:1713-1719.
28. Cohn, J.N , B Levine, M.T. Olivari, V. Garberg, D. Lura, G.S. Francis, A.B. Simon, and T. Rector. 1984. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N. Engl. J. Med. 311:819-823.
29. Benjamin, I.J., J.E. Jalil, L.B. Tan, K. Cho, K.T. Weber, and W.A. Clark. 1989. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ. Res. 65:657-670.
30. Long, C.S., W.E. Hartogensis, and P C. Simpson. 1993. β-adrenergic stimulation of cardiac non-myocytes augments the growth-promoting activity of non-myocyte conditioned medium. J. Mol. Cell. Cardiol 25:915-925.
31. Long, C.S., K. Kariya, L Karns, and P.C. Simpson. 1992. Sympathetic modulation of the cardiac myocyte phenotype: studies with a cell-culture model of myocardial hypertrophy. Basic Res. Cardiol. 87(Suppl. 12):19-31.